Answers are grounded in this paper and cite their sources.
Current approaches to testing new treatments for multidrug resistant bacterial diseases raise scientific and ethical issues for current and future patients, say John Powers and colleagues
No takes yet. Share an insight, caveat, or question.
Powers et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: